Pharmacodynamic interaction mechanisms

Interaction Types - Drug Duets & Duels

• Additive: Combined effect equals the sum of individual drug effects (1 + 1 = 2).
  • Example: Aspirin and acetaminophen for analgesia.
• Synergistic: Combined effect exceeds the sum of individual effects (1 + 1 > 2).
  • Example: Trimethoprim-sulfamethoxazole (Bactrim).
• Antagonistic: One drug diminishes or abolishes the effect of another (1 + 1 < 2).
  • Pharmacologic: Competitive (naloxone + morphine) or non-competitive.
  • Physiologic: Opposite effects on a physiological system (insulin + glucagon).

⭐ Exam Favorite: Penicillins and aminoglycosides are synergistic. Penicillin breaks down the bacterial cell wall, enhancing aminoglycoside entry to the ribosome, thus boosting its efficacy.

Receptor Binding - The Receptor Rumble

• Competitive Antagonism: Reversibly binds to the same receptor site as the agonist.
  • Shifts the dose-response curve to the right (↑ED₅₀), reducing potency.
  • Maximal effect (Emax) is maintained.
  • Can be overcome by increasing agonist concentration.
  • 📌 Mnemonic: Competitive antagonists cause a Right shift, but no Height shift.
• Non-competitive Antagonism: Binds irreversibly to the active site or to an allosteric site.
  • Reduces Emax, lowering efficacy.
  • Cannot be overcome by increasing agonist concentration.
• Partial Agonism: Acts as an agonist but with lower intrinsic activity.
  • Can act as a competitive antagonist in the presence of a full agonist.

⭐ Exam Favorite: A partial agonist like buprenorphine can precipitate withdrawal in a patient on a full agonist like morphine. It competes for µ-opioid receptors but has lower intrinsic activity, causing a net decrease in receptor stimulation.

Signaling Pathways - A Downstream Dilemma

• Occurs when drugs target different receptors but converge on the same intracellular signaling cascade, leading to exaggerated or opposed effects.
• Synergistic Example: Sildenafil (PDE-5 inhibitor) and Nitroglycerin (NO donor) both ↑ cGMP levels, causing profound vasodilation and life-threatening hypotension.
• Antagonistic Example: NSAIDs (↓ prostaglandins) and ACE inhibitors (↓ Angiotensin II) have opposing effects on renal arteriole tone, risking acute kidney injury.

⭐ Contraindication: Never prescribe phosphodiesterase-5 inhibitors (e.g., sildenafil) with nitrates. Allow a washout period of at least 24-48 hours to prevent severe hypotension.

Serotonin Syndrome - A Serotonin Storm

• Pathophysiology: Potentially life-threatening condition from excess CNS serotonergic activity, typically from combining serotonergic drugs.
• Common Culprits:
  • SSRIs/SNRIs, MAOIs, Linezolid, Methylene Blue.
  • Triptans, Tramadol, St. John's Wort.
• Clinical Triad:
  • Autonomic Dysfunction: Hyperthermia, tachycardia, diaphoresis.
  • Neuromuscular Hyperactivity: Clonus (key finding), hyperreflexia (lower > upper limbs), rigidity.
  • Mental Status Changes: Agitation, confusion.
• Management:
  • Discontinue all serotonergic agents.
  • Supportive care (cooling, hydration).
  • Cyproheptadine (5-HT2A antagonist) for severe cases.

⭐ A 2-week washout period is crucial when switching between MAOIs and SSRIs (5 weeks for fluoxetine) to prevent this reaction.

High‑Yield Points - ⚡ Biggest Takeaways

• Pharmacodynamic interactions involve one drug altering another's effect at the site of action.
• Synergism: Combined effect is greater than the sum of individual effects (e.g., TMP-SMX).
• Potentiation: A drug with no intrinsic effect boosts another's activity (e.g., Levodopa-Carbidopa).
• Pharmacologic antagonism: Competition at the same receptor (e.g., naloxone reverses morphine).
• Physiologic antagonism: Different receptors, opposing actions (e.g., insulin vs. glucagon).
• Additive effects: The sum of individual actions from drugs with similar mechanisms.